Search Results
Sep 26, 2025, 08:30 ET Alexandria Real Estate Equities, Inc. Strategically Partners With Lilly on Newest Lilly Gateway Labs at the One Alexandria Square Megacampus in San Diego's Torrey Pines to Accelerate the Development of Life-Changing Medicines
expand the transformative Gateway Labs platform in San Diego," said Hallie E. Kuhn, PhD, senior vice president and co-lead of life science and capital markets at Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments. "Our
More news about: Alexandria Real Estate Equities, Inc.
Sep 25, 2025, 14:14 ET Axon Therapies Raises $32M in Oversubscribed Series A to Transform Heart Failure Treatment
supports clinical trials of a minimally invasive therapy targeting a root cause of heart failure; co-founder Zoar Engelman, PhD, appointed CEO NEW YORK, Sept.
More news about: Axon Therapies
Sep 25, 2025, 14:05 ET Axon Therapies Raises $32M in Oversubscribed Series A to Transform Heart Failure Treatment
supports clinical trials of a minimally invasive therapy targeting a root cause of heart failure; co-founder Zoar Engelman, PhD, appointed CEO NEW YORK, Sept.
More news about: Axon Therapies
Sep 25, 2025, 11:07 ET While It May Go Unnoticed, Loss of Smell May Linger for Years After COVID-19
Horwitz, Jacqueline Becker, PhD at Icahn School of Medicine at Mount Sinai in New York is co-lead author. Hassan Ashktorab, PhD, at Howard University in
More news about: NYU Grossman School of Medicine and NYU Langone Health
Sep 25, 2025, 10:53 ET Breaking Barriers in STEM: Neda Nobari's Visionary Philanthropy Launches Maryam Mirzakhani Presidential Scholarships at San Francisco State University
only the space to excel academically, but also the support to grow as catalysts for progress," said Mia S. Reisweber, PhD, Associate Dean of Students, Division of Student Life, Student Affairs at SFSU. For Nobari, a proud SFSU computer science graduate and lifelong
More news about: MOZAIK Philanthropy
Sep 25, 2025, 09:35 ET Retirement Confidence High Among US Employees, Yet Many Make Basic Financial Mistakes
"Even financially knowledgeable investors often make emotional decisions during market volatility," said Eric Ludwig, PhD, CFP®, Director of the Center for Retirement Income at The American College of Financial Services. "The solution isn't just more education, but plan
More news about: Nationwide
Sep 25, 2025, 09:30 ET Israel Cancer Research Fund Partners with The Mark Foundation for Cancer Research to Support Lung Cancer Project Grant at Weizmann Institute of Science
Research (MFCR) have partnered on a new award, The ICRF-Mark Foundation Collaborative Project Grant, given to Yosef Yarden, PhD, of the Weizmann Institute of Science in Israel. Professor Yarden was awarded $180,000
More news about: Israel Cancer Research Fund
Sep 25, 2025, 09:03 ET Radicle Science Continues to Expand Executive Bench with Industry Leaders to Accelerate Growth
panel discussion on AI accelerating supplement innovation; and Radicle's SVP, Scientific Affairs, Dr. Susan Hewlings, PhD, RD, will speak on the state of sports and active nutrition. About Radicle Science Radicle Science is a health tech trailblazer
More news about: Radicle Science
Sep 25, 2025, 09:00 ET Flat Medical Establishes Clinical Advisory Board for Pain Interventions, Names Dr. Krishnan Chakravarthy as Chairman
Clinical Advisory Board for Chronic Pain Interventions and the appointment of Dr. Krishnan Chakravarthy, MD, PhD, as its inaugural Chairman. This strategic initiative positions Flat Medical to accelerate innovation in chronic pain management technologies and expand
More news about: Flat Medical
Sep 25, 2025, 09:00 ET Challenge Your Score: Workera Debuts Score Appeal to Align Its AI Agent with Expert Human Judgment
reshaping how organizations measure skills, but adoption stalls if the results feel like a black box," said Taylor Sullivan, PhD, Head of Product at Workera. "With Score Appeal, Workera is bringing a human into the loop to build trust so both individuals and leaders can take action
More news about: Workera.ai
Sep 25, 2025, 08:01 ET Breakthrough T1D, Lupus Research Alliance, and National Multiple Sclerosis Society Award Recipients of First Common Mechanisms of Autoimmunity Insight Award
opportunity to continue our collaboration on research that may provide key insights that benefit everyone," Joshua Vieth, PhD, Senior Director of Research at Breakthrough T1D, said. "By working together to advance our collective understanding of autoimmunity, we can reduce gaps
More news about: Lupus Research Alliance
Sep 25, 2025, 07:41 ET Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
firm. The team is led by Srinivas Akkaraju, who has over twenty-seven years of industry experience and has an MD and a PhD in Immunology from Stanford University. Contact: Respira Therapeutics, Inc.John
More news about: Respira Therapeutics, Inc.
Sep 25, 2025, 07:00 ET Daymark Health Raises $20M in Series A Funding to Scale Tech-Enabled Cancer Care Platform to Thousands of Patients
personalized care for patients with cancer, while improving outcomes and reducing avoidable costs," said Aman Mahajan, MD, PhD, Partner at Healthier Capital. "Daymark is delivering a transformational model of personalized, high-quality, value-based cancer care." "Daymark
More news about: Daymark Health
Sep 25, 2025, 06:30 ET AL-S Pharma Appoints Internationally Recognized Neurologist and Clinical Trial Expert Prof. Dr. Angela Genge as Chief Medical Officer
very happy to welcome Prof. Dr. Genge in an expanded role at this exciting time for AL-S Pharma," said Michael Salzmann, PhD, Chief Executive Officer of AL-S Pharma. "As an internationally recognized leader in ALS, Prof. Dr. Genge's expertise will be pivotal to guide our AP-101
More news about: AL-S Pharma AG
Sep 24, 2025, 18:30 ET FDA Announcement Brings National Attention to Leucovorin; TACA Highlights Hope for Families with Autism
TACA Physician Advisory Board members, Dr. Dan Rossignol, MD, and Dr. Richard Frye, MD, PHD have been at the forefront of leucovorin research and continue to use the drug in their practices to support children with autism. "I am grateful
More news about: The Autism Community in Action (TACA)
Sep 24, 2025, 16:51 ET Study Reveals How Tick-Borne Encephalitis Virus Enters Cells
Jacob Berrigan, Margaret Kielian, Ph.D., and Evripidis Gavathiotis, Ph.D. Other authors include Renata Varnaite, PhD., Wanda Christ, Ph.D., Mansoureh Shahsavani, Ph.D., and Anna Falk, Ph.D. (all at Karolinska
More news about: Albert Einstein College of Medicine
Sep 24, 2025, 16:18 ET INTERNATIONALE GESELLSCHAFT FÜR HAARWIEDERHERSTELLUNGSCHIRURGIE VERANSTALTET 33. WELTKONGRESS, 23. bis 25. OKTOBER 2025, IN BERLIN, DEUTSCHLAND, MIT AUSVERKAUFTEM LIVE-CHIRURGIE-WORKSHOP am 26
Leslie Castelo-Soccio, MD, PhD, USA - „Mikrobiom in der Haarwiederherstellung"David Saceda, MD, PhD, Spanien - „Behandlung von frontaler fibröser Alopezie"Ulrike Blume-Peytavi, MD, PhD, Deutschland - „Aktuelle Informationen
More news about: International Society of Hair Restoration Surgery
Sep 24, 2025, 16:12 ET SOCIÉTÉ INTERNATIONALE DE CHIRURGIE DE RESTAURATION ACCUEILLE LE 33e WORLD CONGRESS, DU 23 AU 25 OCTOBRE 2025, À BERLIN, EN ALLEMAGNE, AVEC UN ATELIER DE CHIRURGIE EN DIRECT, LE 26 OCTOBRE, QUI S'EST TENU À COUVERT
Castelo-Soccio, MD, PhD, USA - « Le microbiome dans la restauration capillaire ».David Saceda, MD, PhD, Espagne - « Prise en charge de l'alopécie fibrosante frontale »Ulrike Blume-Peytavi, MD, PhD, Allemagne - « Mises à
More news about: International Society of Hair Restoration Surgery
Sep 24, 2025, 16:10 ET Russia, Israel, and the End of Times: A Prophetic Look at Today's Conflicts
Sept. 24, 2025 /PRNewswire/ -- Author and pastor Dr. Abraham DeAlmeida, PhD, connects historical and current events with scripture and end-times theology in his latest publication, "Russia's Final
More news about: Author Solutions, Inc.
Sep 24, 2025, 14:28 ET Unlikely Collaborators Presents: "Scared of Failure: Do It Anyway" with Ellen Bennett
Kaufman, PhD, nutrition therapist Kim Shapira, MS, RD, mythologist John Bucher, Harvard Business School professor and author Michael Norton, PhD. and Visionary
More news about: Unlikely Collaborators
Sep 24, 2025, 14:13 ET Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
well as the investigators and the site staff who continue to participate in the trial." Robert Montgomery, MD, PhD, New York University Langone Health, said: "There have been few major breakthroughs in desensitization strategies in kidney
More news about: Hamlet BioPharma AB
Sep 24, 2025, 14:06 ET Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
well as the investigators and the site staff who continue to participate in the trial." Robert Montgomery, MD, PhD, New York University Langone Health, said: "There have been few major breakthroughs in desensitization strategies in kidney
More news about: Hamlet BioPharma AB
Sep 24, 2025, 11:44 ET Native Forward Scholars Fund Receives $50 Million from MacKenzie Scott, Marking Largest Award to Date in Indian Country
years, it has empowered over 22,000 scholars from more than 500 Tribes in all 50 states and contributed to over 1,700 law degrees and more than 2,200 PhD degrees. By pairing scholarships with meaningful, culturally congruent student support and programming, Native Forward has succeeded in increasing the
More news about: Native Forward Scholars Fund
Sep 24, 2025, 11:00 ET BranchLab Launches Scientific Advisory Board Featuring Two of the Country's Leading AI Academic Researchers
applications of its technologies. "This advisory board ensures we stay deeply connected to the cutting edge of AI research," said Kat Drake, PhD, Vice President of Data Science and AI at BranchLab. "Their insight will sharpen our thinking and accelerate our ability to translate innovation into
More news about: BranchLab Inc
Sep 24, 2025, 10:33 ET Multiple Choice World Premiere Draws 300+ in Newport, Calls for Bold Education Reform
young people for purposeful lives in a world shaped by rapidly advancing technology. A former top-ranked U.S. venture capitalist, Dintersmith holds a PhD in Engineering from Stanford and has been recognized nationally for his contributions to education, including the NEA's Friend
More news about: Ted Dintersmith